REG - Inspiration Health - Publication of AR, accounts & notice of AGM

Inspiration HealthcareAnnouncement

13/06/2025 09:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250613:nRSM7714Ma&default-theme=true

RNS Number : 7714M  Inspiration Healthcare Group PLC  13 June 2025

 

Inspiration Healthcare Group plc

 

("Inspiration Healthcare", the "Company" or the "Group")

 

Publication of Annual Report and Accounts for the year ended 31 January 2025

Notice of Annual General Meeting

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering specialist neonatal intensive care medical devices,
announces that the Annual Report and Accounts for the year ended 31 January
2025 and the notice of its Annual General Meeting ("AGM") have been published
on the Company's website at www.inspirationhealthcaregroup.com and will be
posted to shareholders later today.

 

AGM and voting

The AGM of Inspiration Healthcare will be held at 12:00 p.m. (UK time) on 24
July 2025 at the Company's registered office, Unit 7/8 Commerce Park, Commerce
Way, Croydon, England, CR0 4YL.

 

Voting by proxy

Shareholders will not receive a hard copy form of proxy for the AGM in the
post. Instead, shareholders will be able to appoint a proxy electronically via
the Investor Centre app or web browser at
https://uk.investorcentre.mpms.mufg.com/
(https://uk.investorcentre.mpms.mufg.com/) , shareholders will need to log
into your Investor Centre account or register if that shareholder has not
previously done so. To register, shareholders will need an Investor Code, this
is detailed on your share certificate or available from our Registrars, MUFG
Corporate Markets. Proxy votes must be received by no later than 12.00 pm on
22 July 2025. Alternatively, shareholders may submit a proxy vote via CREST
where applicable. Shareholders who are an institutional investor may also be
able to appoint a proxy electronically via the Proxymity platform (more
information can be found in the notice of meeting).

 

Request a hard copy form of proxy

You may request a hard copy form of proxy directly from the Registrars by
emailing MUFG Corporate Markets at shareholderenquiries@cm.mpms.mufg.com.
Alternatively, you can request a hard copy proxy card by calling MUFG
Corporate Markets on 0371 664 0300. Calls are charged at the standard
geographic rate and will vary by provider. Calls outside the United Kingdom
will be charged at the applicable International rate.  Lines are open between
09:00 - 17:30, Monday to Friday excluding public holidays in England and
Wales.

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                          Tel: +44 (0)330
                                                           175 0000
 Raffi Stepanian, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                                                                        Tel: +44 (0)20
                                                                                                     3100 2000
 Will Goode

 Emma Earl

 Will King

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                               Mob: +44 (0) 7876 741 001
 Rachel Broad

 

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its Manufacturing and Technology Centre in
Croydon, South London, and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAPKNBDFBKKPAD